Not sure what management is thinking. Why would they not wait a least a few weeks to allow the momentum to rally the price higher, plus it doesn't have the appearance that the postive news was issued just to get a price dump for a higher offering price. I'm not happy because their stupidity and bad timing has lost me a lot on money.
I think you are a little too optimistic, I think will head over today's high of $6 though, and make it to the mid $7's, regardless of how the overall biotech market does.
CANF did that on a Fast Track and not on great results results like CTRV had, so this has more potential to easily rally over $7 tomorrow.
I am continually amazed at how ignorant some analysts are and equally amazed that investors actually take their advice. GILD's pricing model is solving the problem of high health care costs by elliminating the disease/virus. GILD's Harvoni/Solvaldi will never be subject to any regulation for the simple reason that it is one time treatment and does not fall under the same defination as an ongoing treatment drug. One day the street will realise this along with the fact that no drug will compete with Harvoni/Solvaldi as they will always be 2 steps ahead plus the world will always have plenty of HepB&C/NASH patients.
I have to admit you were right about this stock being too expensive up in the 60's and 70's, so I guess I'm eating crow. Apparently many biotechs were too expensive. I may get back in as well but now there are 4 other biotechs that I also like that are discounted as well. My top 5 are GILD, MDVN, CELG, VRTX and AMAG in that order. Since you seem to have a good handle on this game which of these do you think would be best to swing trade and/or hold for long term at this time?
I'm not saying this is good or bad but would think it would go up a least a little today?? Either it's being held down for cheaper purchase price or the big money is not convinced that other biotechs are interested in purchasing.
Trying to determine entry point. There is defiately no rush but price seems to have regressed since recent positive lab news so maybe time to pull the trigger (however IBB may still be volitile).
See it happen this way time and time again. When everyone is saying GILD's going to $150-$200 take profits and when everyone starts saying it's going to $85 or under it's time to buy.
Based on her own principles her appearance price should be regulated to provide a discount, plus she can be cloned after 7 years in politics so there are muliple Hilary's competing for the same gigs.
The government doesn't like it when you lie, withold information or don't cooperate with them. They are about to make her look bad and her popularity will continue to decline.
It was a quick announcement on CNBC and I think most missed it, will make headlines over the weekend.
Just do a 'Baker Brothers Can-Fite' search and you'll see it.
Didn't think we'd see $100 again but when the IBB is down over 5% I guess you can expect it.
You can't be serious, you're comparing an industry that emits toxins into the air to one that saves people's lives. The only ones worrying about Hilary tweet are retail investors, so the pros are loving this as they know it will blow over as it always does and they'll get GILD as a greatly discounted price.
You guys are over reacting, this is just a political stunt to try and gain votes. Many politicians have tried to regulate pricing before for political gain and not one has come close, so you think all of af sudden Hilary will be able to do something. GILD will never have to decrease it's pricing because of government legislation as it will never pass, plus GILD can easily cost justify as it's a cure and reduces long term care costs.
There are about 2 or 3 of you that are very annoying on the GILD board. For those don't go away mad, just go away.
I am sick and tired of you Arrow Air heads thinking GILD owes you something. Sell that dumb thing and buy GILD.
I just got back in today. Loaded up average around $46. Nothing has changed fundimentially within AMAG. Biotech sediment is bottoming with Hillary stuff, so now that's in the rear view and IBB is down 17% expect shorts to cover and this to rally to where it should be around $75-$85. You won this battle but AMAG will win in the long run.